- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Ad26.COV2.S.
Displaying page 1 of 1.
EudraCT Number: 2020-005801-14 | Sponsor Protocol Number: VAC31518COV3003 | Start Date*: 2021-02-08 | |||||||||||
Sponsor Name:Janssen Vaccines & Prevention B.V. | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-Controlled Phase 3 Study to Evaluate 3 Dose Levels of Ad26.COV2.S Administered As Single-Dose And Two-Dose Schedules in Healthy Adults | |||||||||||||
Medical condition: Healthy Volunteers (Prevention of SARS-CoV-2-mediated COVID-19) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002584-63 | Sponsor Protocol Number: VAC31518COV2001 | Start Date*: 2020-08-26 |
Sponsor Name:Janssen Vaccines & Prevention B.V. | ||
Full Title: A Randomized, Double-blind, Placebo-controlled Phase 2a Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults Aged 18 to 55 Years Inclusive and Adults ... | ||
Medical condition: Healthy Volunteers (Prevention of COVID-19) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) ES (Temporarily Halted) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003643-29 | Sponsor Protocol Number: VAC31518COV3009 | Start Date*: 2020-11-10 | |||||||||||
Sponsor Name:Janssen Vaccines & Prevention B.V. | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older E... | |||||||||||||
Medical condition: Healthy Volunteers, with or without comorbidities (Prevention of SARS-CoV-2-mediated COVID-19) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) ES (Ongoing) BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001483-28 | Sponsor Protocol Number: VAC31518COV1001 | Start Date*: 2020-07-14 |
Sponsor Name:Janssen Vaccines & Prevention B.V. | ||
Full Title: A Randomized, Double-blind, Placebo-controlled Phase 1/2a Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26COVS1 in Adults Aged 18 to 55 Years Inclusive and Adults Aged 65 Ye... | ||
Medical condition: Healthy volunteers (Prevention of COVID-19) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
